Last reviewed · How we verify

NCT07101653

Exercise-Induced Irisin and Brain Changes

Completed NA Last updated 3 August 2025
What this trial tests

NA trial testing Exercise in Multiple Sclerosis in 21 participants. Completed in 15 June 2025.

Timeline
15 October 2024
Primary endpoint
15 November 2024
15 June 2025

Quick facts

Lead sponsorFirat University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment21
Start date15 October 2024
Primary completion15 November 2024
Estimated completion15 June 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Firat University

Who can join

Adults 19 to 65, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This single-blind, randomized controlled trial will employ a two-arm parallel design (exercise group vs. control group) with a 12-week intervention period. Sex-stratified randomization will be implemented using SPSS 25.0 (IBM Corporation, Armonk, NY, USA) to ensure balanced group allocation. All outcome measures will be assessed at baseline and post-intervention.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Exercise induces structural brain changes and elevates irisin levels and enhances functional performance in multiple sclerosis a pilot randomized study.
    Bilek F, Deniz G, Elidar G, Ercan Z, et al · · 2026 · PMID 41484293 · DOI 10.1038/s41598-025-33434-4

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Firat University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07101653.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing